MedTrace Logo

Effect of a Novel Nutraceutical on Weight Loss and Weight Maintenance in Obese Subjects

NCT01656681 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2018-05-18

No results posted yet for this study

Summary

The purpose of this 2-stage intervention study is to investigate the effect of a novel nutraceutical (containing tetrahydro iso-alpha acids derived from hops) on weight loss and weight loss maintenance in obese participants.

Conditions

Interventions

DIETARY_SUPPLEMENT

THIAA

A tablet containing 400 mg tetrahydro iso-alpha acids, 3 times a day

DIETARY_SUPPLEMENT

Placebo

Placebo tablet

Sponsors & Collaborators

  • MetaProteomics LLC

    lead INDUSTRY

Principal Investigators

  • Joseph J Lamb, MD · MetaProteomics / Metagenics

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-11-30
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01656681 on ClinicalTrials.gov